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Abstract: Haemorrhagic septicaemia (HS) is one of the economically most important bacterial diseases of large ruminants. In the
present investigation, a total of 156 buffaloes (Murrah, Jafarabadi, and Bhadawari breeds) at a semiorganized farm after administration
of HS alum precipitated killed vaccine were screened serologically for the presence of anti-HS antibodies by single dilution indirect
enzyme linked immunosorbent assay (iELISA). Out of 156 buffaloes tested for presence of anti-HS antibodies, a greater proportion of
buffalo (67.94%) had protective level of anti-HS antibodies even after 90th day post vaccination.
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1. Introduction
Haemorrhagic septicaemia (HS) is one of the economically
most important bacterial diseases mainly of cattle and
buffaloes. The disease is caused by a gram-negative
coccobacillus Pasteurella multocida subsp. multocida
belonging to the family Pasteurellaceae [1,2]. In India and
Africa, serotypes B:2 and E:2, respectively are responsible
for causing HS in large ruminants [3], although serotypes
A:1 and A:3 have also been linked. HS affected buffalo
exhibit respiratory sounds, profuse salivation, dyspnoea,
mucous nasal discharge, high temperature, reduced
appetite, restlessness, mandibular and neck region oedema,
and redness [4]. According to 19 th livestock census
(2012), the total bovine population was 299.9 million in
India (http://dahd.nic.in/sites/default/filess/Livestock%20
%205_0.pdf). Out of this, a significant percentage
(approximately 36%, 108.7 million) consisted of buffalo,
which makes India rank first in the buffalo population in
the world. Nearly half of this buffalo population (51.05
million) consists of milch buffalo contributing around
50% of the total milk production. India is the largest
producer of buffalo milk and contributes 68% of the total
world buffalo milk produced [5]. As per the Department
of Animal Husbandry, Government of Madhya Pradesh,
the state ranks fourth in the country for milk production
(10.78 million tonnes during the year 2014–2015) with

383 g milk availability per capita per day, higher than
the national average of 313 g (http://www.mpdah.gov.
in/upload/10_year_achievement_with_graph.pdf). The
total national gross domestic product (GDP) contribution
of livestock sector was 5.26% while livestock in Madhya
Pradesh contributes a quite higher 8%–10% to the GDP
of the state. In 2016, India received US $ 3810 million
export value of buffalo meat. Estimated economic losses
due to HS in India are to the tune of US $ 750 million [6].
In India, HS vaccination is routinely practiced in large
ruminants for prevention and control of the disease in
endemic areas and contain the losses. According to the
Department of Animal Husbandry Dairying and Fisheries,
Government of India, there was a significant reduction
(more than 50%) in the number of HS outbreaks from 698
(2011–2014) to 300 (2014–2017) (http://dadf.gov.in/sites/
default/filess/New%20initiatives%20for%20doubling%20
farmers.pdf). Microtiter agglutination test (MAT),
indirect hemagglutination assay (IHA), and enzyme linked
immunosorbent assays (ELISA) are usually employed to
detect serum antibody levels in immunized animals [7].
The ELISA detects immune response to soluble antigens
and generally used to detect IgG antibodies. The present
study reports antibody response against alum precipitated
HS vaccine in buffaloes reared at a semiorganized farm of
Madhya Pradesh.
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2. Materials and methods
2.1. Geographical location
Madhya Pradesh State Livestock and Poultry Development
Corporation has a semi-organized Animal Breeding
Farm at Kiratpur–461111 (22.5395° N, 77.7645° E), Itarsi,
District Hoshangabad, Madhya Pradesh. At the time of
this study, the farm had 250 buffaloes and 6 cattle. The
place has a subtropical climate; a hot dry summer (April–
June) followed by monsoon rains (July–September), and a
cool and relatively dry winter [8].
2.2. Vaccine
HS alum precipitated killed vaccine produced by Institute
of Animal Health and Veterinary Biologicals (IAH&VB),
Rasalpura, Mhow-453446, Indore, Madhya Pradesh was
used in the present study.
2.3. Animals
A total of 156 adult buffalo of Murrah, Jafarabadi, and
Bhadawari breeds (>3 years of age) being reared at
the Animal Breeding Farm, Kiratpur were used in the
present study. The buffaloes were administered with HS
alum precipitated killed vaccine @5mL by following the
subcutaneous route in the month of June in 2015. Animals
received the first vaccine after attaining the age of 6 months
and thereafter a booster dose every year.
2.4. Collection of blood samples, separation of serum,
and transportation and processing of samples
Blood (8–10 ml) was collected aseptically from the jugular
vein of each buffalo only once on the 90th day post
vaccination, allowed to clot and serum was collected in
the sterile cryovials. Containers were allowed to clot under
the shade for half an hour duration. The serum samples
were transported under cold chain conditions, initially at
the Animal Breeding Farm, Kiratpur; then to Department
of Veterinary Microbiology, College of Veterinary Science
and Animal Husbandry, Nanaji Deshmukh Veterinary
Science University, Mhow-453446, Madhya Pradesh.
Thereafter these samples were carried to the Department
of Veterinary Microbiology, College of Veterinary
Sciences, Lala Lajpat Rai University of Veterinary and
Animal Sciences (LUVAS), Hisar – 125004, Haryana under
cold chain conditions and were stored at deep freezing
conditions (–20 °C) till used.
2.5. Single dilution indirect ELISA
The single dilution indirect ELISA (iELISA) for detection
of serum antibodies against Pasteurella multocida (causing
haemorrhagic septicaemia) developed in the Department
of Veterinary Microbiology, COVS, LUVAS, Hisar
was employed in the present investigation and briefly
described.
2.5.1. Coating of microplates with antigen
The ELISA microplates were coated with sonicated
antigens of Pasteurella multocida (approx. 1 ng/ well).
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The antigen coated plates were incubated at 37 °C for 1 h
and transferred to 4 °C. Next day, the ELISA plates were
washed by flooding wells with wash buffer and decanting
for 3 cycles and were finally tapped to dry. Meanwhile, the
buffalo sera samples were kept at room temperature for
thawing.
2.5.2. Testing of serum samples by iELISA
For dilution of sera samples, 50 µL of the diluent buffer was
added to well A1 and 45 µL to all the remaining wells of
the ELISA plate. 5 µL of each negative and positive serum
controls were added to the B1 to F1 and G1 to H1 wells,
respectively. Now, 5 µL of each test serum sample (1-88)
was added to the respective wells (A2 to H12) of the ELISA
plate (final volume of 1:10 in 50 µL volume). The plates
were incubated at 4 °C for overnight incubation. Next day,
the ELISA plates were washed as described earlier and 50
µL of the 1:1000 tracing antibody (monoclonal antibody
cross reacting equally with buffalo and cattle IgG) was
added in all the wells of the ELISA plates and incubated at
37 °C for 1 h. After incubation, the plates were washed and
dried as described earlier, followed by addition of 50 µL of
the 1:10,000 goat anti-mouse IgG horseradish peroxidase
(HRPO, Sigma Aldrich) conjugate and were incubated at
37 °C for 1 h. After washing and drying, 50 µL of the 1:100
diluted stock TMB substrate solution was added in each
of the wells and plates kept in the incubator at 37 °C for 5
min for development of the blue colour in positive cases.
The colour development reaction was stopped by adding
50 µL of stopping solution (1 M H2SO4) to each well.
Optical density (OD) of each well was measured by ELISA
Reader (Tecan, Austria) at 450 nm and the antibody titres
(log10) were calculated.
2.6. Interpretation
The results were interpreted as follows: the serum samples
with antibody titers <1.50 log10 were considered as ‘not
protected’; antibody titers between 1.5 log10 and 1.80 log10
as ‘partially protected’, and those with antibody titer >1.8
log10 as ‘protected’.

3. Results
Serum antibody titres ranging from 1.4803 log10 to
2.2351 log10 were observed by iELISA for the presence of
antibodies against HS [Table 1, Table 2, Figure 1]. Of the
total 156 buffaloes, 4, 52, and 100 buffaloes demonstrated
serum antibody titres <1.5 log10 (1.4803 log10 to 1.4892
log10), 1.5 log10 to 1.8 log10 (1.5296 log10 to 1.7922 log10)
and >1.8 log10 (1.7997 log10 to 2.2351 log10), and were
categorized as ‘not protected’, ‘partially protected’ and
‘protected’ against HS, respectively [Figure 2]. Among the
100 buffaloes categorized as ‘protected’ a larger proportion
of animals had serum antibody titres in the range 1.8 log10
to 1.9 log10.
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Table 1. Antihaemorrhagic septicaemia antibody titres in serum from buffaloes vaccinated with
alum precipitated haemorrhagic septicaemia killed vaccine by single dilution indirect enzyme
linked immunosorbent assay and not-protected/partially protected.
Buffalo

Antibody titre

Buffalo

Antibody titre

Buffalo

Antibody titre

179*

1.4803

283

1.6371

56

1.6987

1516*

1.4867

Uk20

1.6445

119

1.7017

9*

1.4879

98

1.6447

189

1.7308

164*

1.4892

135

1.6452

8

1.7405

1512

1.5296

176

1.6488

41

1.7410

148

1.5375

190

1.6566

Uk10

1.7412

183

1.5532

174

1.6604

1010

1.7488

285

1.5547

289

1.6616

223

1.7584

2516

1.5717

286

1.6637

186

1.7718

193

1.5719

1581

1.6644

54

1.7766

91

1.5726

147

1.6664

192

1.7814

115

1.5798

168

1.6716

292

1.7814

167

1.5807

267

1.6733

1513

1.7821

5

1.5886

85

1.6743

57

1.7823

2519

1.6121

44

1.6787

127

1.7885

2504

1.6158

4

1.6916

132

1.7886

18

1.6248

172

1.6917

2507

1.7911

2505

1.6267

242

1.6955

225

1.7922

2517

1.6317

6

1.6966

*Not protected, rest-partially protected

4. Discussion
Vaccination of animals not only protects susceptible
population from the infection but also by means of
herd immunity that confers indirect protection to the
unvaccinated population. Increased level of humoral
immunity or antibody response to the immunization
prevents circulation of infectious agent in susceptible
populations [9,10]. Vaccination is the key to prevent and
control outbreaks of HS in susceptible livestock population
in endemic areas. Buffaloes are more susceptible than
cattle to HS caused by P. multocida, and hence it is of
utmost importance to vaccinate these animals specifically
those being reared at semiorganized or organized farms
in large numbers. It is suggested to implement control
strategies in buffalo dominated areas with a higher priority
[11]. Buffalo from Madhya Pradesh contributed 4309.19
thousand tonnes of milk production and 15.1 thousand
tonnes of meat production [12]. Considering the economic
contribution from buffalo to Madhya Pradesh state
economy to reduce losses due to HS various kinds of single
(alum precipitated/aluminium hydroxide gel/mineral oil
adjuvanted) and combined (combined foot-and-mouth

disease-haemorrhagic septicaemia-Blackquarter) HS
vaccines are continuously being developed and tested for
immunization of livestock against these diseases in the
endemic areas world-wide including India [13].
Bacterins from plain broth, or alum precipitated and
aluminium hydroxide gel vaccines, oil adjuvant vaccine,
live vaccines and subunit vaccines are used in veterinary
practices for prevention and control of various diseases
in animals. Due to its availability in the state, cost
effectiveness, and ease in injection [14,15,16], HS alum
precipitated vaccine is the most commonly used vaccine
for immunization of susceptible livestock population for
prevention and control of HS caused by P. multocida. There
was an increased awareness for vaccination as an overall
including against HS in Madhya Pradesh. Approximately
207.08 lakh vaccine doses were administered in 2014–
2015 compared to 70.79 lakh vaccine doses in 2005
owing to better animal husbandry services. Knowledge
of the proportion of immune to nonimmune animals
and the levels of antibodies in the herd will be helpful for
ascertaining the severity of the outbreak and initiation
of possible prophylactic and therapeutic measures for
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Table 2. Antihaemorrhagic septicaemia antibody titres in serum from protected buffaloes vaccinated with alum precipitated
haemorrhagic septicaemia killed vaccine by single dilution indirect enzyme linked immunosorbent assay.
Buffalo

Antibody titre

Buffalo

Antibody titre

Buffalo

Antibody titre

Buffalo

Antibody titre

163

1.7997

1582

1.8274

224

1.8478

145

1.8921

138

1.8006

128

1.8288

38

1.8482

2502

1.8939

2503

1.8014

1559

1.8296

49

1.8484

180

1.8942

62

1.8028

1582

1.8325

123

1.8491

143

1.8943

197

1.8032

39

1.8327

10

1.8493

117

1.8974

17

1.8043

30

1.8338

1518

1.8542

290

1.8978

117

1.8054

181

1.8342

2508

1.8595

36

1.9124

121

1.8089

2506

1.8345

268

1.8600

1057

1.9185

195

1.8105

50

1.8346

1562

1.8611

134

1.9188

2511

1.8109

130

1.8347

165

1.8632

300

1.9227

21

1.8116

22

1.8352

236

1.8676

2515

1.9272

177

1.8116

169

1.8357

118

1.8703

87

1.9294

3

1.8119

144

1.8359

188

1.8732

102

1.9522

146

1.8127

1511

1.8361

178

1.8773

254

1.9688

37

1.8148

99

1.8367

116

1.8781

140

1.9739

149

1.8151

162

1.8367

45

1.8801

142

1.9774

88

1.8163

2512

1.8371

141

1.8809

269

1.9897

2501

1.8182

1315

1.8372

173

1.8811

139

1.9946

185

1.8189

288

1.8383

171

1.8813

1520

1.9967

2514

1.8208

229

1.8391

136

1.8825

175

2.0037

86

1.8212

1518

1.8396

194

1.8838

124

2.0056

184

1.8215

2513

1.8404

191

1.8866

161

2.0118

48

1.8218

259

1.8422

150

1.8877

100

2.0124

176

1.8232

133

1.8439

226

1.8896

89

2.0202

1519

1.8238

132

1.8474

287

1.8897

51

2.2351

2.00 log10 and above

6

1.9 log10 to 2.00 log10

13

1.8 log10 to 1.9 log10

81

1.5 log10 to 1.8 log10

52

Less than 1.5 log10

4
0

20

40

60

80

100

No of buffalo

Figure 1. Number of buffalo showing antihaemorrhagic
septicaemia antibody titres in serum vaccinated with alum
precipitated killed haemorrhagic septicaemia vaccine.

future disease outbreak(s), if any. It is necessary to monitor
vaccinated animals to ascertain protective serological
response in individual animal as well as at herd level.
Although for measurement of immunity in vaccinated
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animals, passive mouse protection test, IHA and ELISAs
are available. ELISAs have been considered to be the most
suitable assay for screening large numbers of serum samples
to detect humoral response against vaccination [17,18].
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2.56%
Protected

32.05%

Partial Protected
67.94%

Not Protected

Figure 2. Percent of buffalo showing different protection
levels of antihaemorrhagic septicaemia antibody titres
in serum vaccinated with alum precipitated killed
haemorrhagic septicaemia vaccine.

Hence, a serological test, iELISA developed indigenously was
employed for screening the buffalo population immunized
with alum precipitated HS killed vaccine to evaluate anti-HS
antibody titers and categorized into one of the criteria: ‘not
protected’, ‘partially protected’, and ‘protected’ against HS. In
the present investigation, 67.94%, 32.05%, and 2.56% buffalo
were grouped in one of the 3 groups i.e. ‘protected’, ‘partially
protected’, and ‘not protected’, respectively on 90 days post
primary vaccination against HS.
Various reports indicated maintenance of varied
duration of reliable immunity from 3 to 9 months in the
vaccinated animals [18]. In the present study, quite a large
proportion of buffaloes (106) were categorized as ‘protected’
but a significant proportion (52) remained ‘partially
protected’, and few (4) ‘not protected’. Booster vaccination
after priming the animals had shown to confer higher
duration of protection [19]. Higher antibody titers up to
14 months postvaccination have been reported in animals
vaccinated with HS subunit vaccine though such vaccines
are not available commercially in India. Aerosol vaccines
(aerosol intranasal spray of live vaccines) were shown to
protect buffalo calves for 7 months post vaccination against
HS. The duration of protection against challenge increased
up to 12 months when the same animals were given
booster dose one month after primary vaccination [20]. In
India, herbal adjuvant based vaccinated animals showed
high levels of antibody titres 180 days post vaccination as
compared to traditional alum precipitated vaccine (reduced
antibody titres after 150 days postvaccination) against HS
[21]. In one of the studies, researchers opined for annual
back passage for the vaccine seed culture to prepare vaccines
with improved potency [22].
Since occurrence of HS is higher in buffalo specifically in
young calves, this species needs to be immunized regularly
in a systemic manner [23]. Though the buffalo in the present
study were regularly vaccinated for protection against HS
and proper feeding practices were employed, they were rarely
monitored for trace minerals and vitamin deficiencies, if any.

Positive effect of vitamin E and selenium supplementation on
antibody titres to HS vaccine was studied [24]. Hence, in our
study the buffalo having low levels of antibody titres might
be attributed to nutritional deficiencies. Immunosuppressive
effect to haemorrhagic septicaemia vaccination in T. evansiinfected buffalo-calves were also found [25]. In future,
such detailed studies on buffalo population of the state can
be planned. Therefore, even after vaccination the animals
must be closely monitored by physical examination and
serological testing and standard livestock managemental
practices including deworming must be implemented [26].
Combined HS and FMD vaccines produced better antibody
titer which lasted for longer duration [27]. Large ruminants
in Madhya Pradesh are also affected by FMD. Hence, it will
be worthy to administer combined vaccines for protection
against HS and FMD to buffalo of Madhya Pradesh in India.
Further, use of combined vaccines (HS and FMD/HS, FMD
and BQ) are better suited to minimize efforts required in
vaccinating animals.
Based on the findings in the present study, it can be
concluded that higher (67.94%) herd immunity against HS
was detected in buffalo from the semiorganized farm. The
present study will help to understand the formulation of
better vaccination strategies for prevention and control of
HS in buffalo of Madhya Pradesh in India.
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